Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Market Movers Today: Alnylam Pharmaceuticals, Inc. (ALNY), Snap Inc (SNAP), Sellas Life Sciences Group Inc (SLS), Intel Corporation (INTC), and More

Alkermes PLC (NASDAQ:ALKS) (Benzinga)
Alkermes plc tumbled 20.5 percent to $46.07 after the U.S. Food and Drug Administration said it won’t review the company’s therapy ALKS-5461. Alkermes, which mostly focuses on treatments for central nervous system diseases, said in a press release it received a Refusal to File letter from the FDA regarding its New Drug Application (NDA) for ALKS-5461.

Geron Corporation (NASDAQ:GERN) (The Motley Fool)
What happened: Geron Corporation (NASDAQ:GERN), a small-cap drugmaker, saw its shares continue their recent downturn Monday by falling by as much as 11.3% in early-morning trading. After gaining more than 200% earlier this year, the biotech’s shares have now shed over 33% of their value in just the past week. Geron’s stock is drifting lower in response to criticism from STAT’s Adam Feuerstein regarding the efficacy of the company’s one and only drug candidate, imetelstat.

Tesla Inc (NASDAQ:TSLA) (CNBC)
Tesla shares are plunging after the company announced a large recall and revealed more details about a fatal Model X crash last month. The company on Thursday announced a voluntary recall of 123,000 Model S vehicles because of an issue with a power steering component. Tesla then revealed on Friday that the Model X vehicle involved in a fatal crash last month had its Autopilot system activated. The National Transportation Safety Board, the government agency investigating the crash, said on Sunday it was “unhappy” that Tesla made public information about the incident.

Netflix, Inc. (NASDAQ:NFLX) (MarketWatch)
Shares of Netflix Inc. fell on Monday, with the online-moving streaming company poised to close below a closely watched level for the first time this year. The stock NFLX, -5.70% fell 3.5% and was on track for its sixth decline of the past eight. With the decline, Netflix fell below its 50-day moving average, a gauge that is seen as an indicator of short-term momentum trends. The stock hasn’t closed below the level since Dec. 29, although it fell below it on an intraday basis in the past two sessions.

Amazon.com, Inc. (NASDAQ:AMZN) (Reuters)
(Reuters) – Shares of Amazon.com Inc (AMZN.O) fell 6 percent on Monday after U.S. President Donald Trump again attacked the online retailer over the pricing of its deliveries through the United States Postal Service and promised unspecified changes. “Only fools, or worse, are saying that our money losing Post Office makes money with Amazon,” Trump tweeted. “They lose a fortune, and this will be changed. Also, our fully tax paying retailers are closing stores all over the country…not a level playing field!” Shares of the company were down 5.9 percent at $1,362.48, wiping out nearly $45 billion from its market value.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.